Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

NCT00421954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Schizophreniform Disorder
Schizoaffective Disorder
Psychosis
Depressive Disorder, Major
Bipolar Disorder

Interventions

DRUG: Ziprasidone

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]